Human Trials of an Ebola Vaccine Launch

The National Institutes of Health and GlaxoSmithKline are launching the first fast track human trials of an ebola vaccine. GlaxoSmithKline vice president of U.S. public policy Donna Altenpohl discusses the trials on the News Hub with Tanya Rivero. Photo: AP.

Advertisement